Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 237,148,153 papers from all fields of science
Search
Sign In
Create Free Account
ERBB4 wt Allele
Known as:
ERBB-4
, HER4
, HER-4
Expand
Human ERBB4 wild-type allele is located within 2q33.3-q34 and is approximately 1156 kb in length. This allele, which encodes receptor tyrosine…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
13 relations
2q33.3-q34
Cell Proliferation Regulatory Process
ERBB2 Signaling Pathway
ERBB4 Receptor Protein Tyrosine Kinase
Expand
Broader (1)
ERBB4 gene
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Quantitative analysis of HER family proteins using mass spectrometry as a predictive tool of response to anti-HER therapies in breast cancer
P. Nuciforo
2016
Corpus ID: 165004190
Introduccion: La expresion desregulada y la actividad de los miembros de la familia HER es frecuente en el cancer de mama (CM…
Expand
2014
2014
Effect of ErbB4 on Triple Negative Breast Cancer Cell Growth and Migration
A. Yousif
2014
Corpus ID: 68537002
Members of the ErbB subfamily of receptor tyrosine kinases are critical regulators of normal mammary gland development, and…
Expand
2013
2013
Erratum: Essential erbB family phosphorylation in osteosarcoma as a target for CI‐1033 inhibition
D. Hughes
,
Dafydd G. Thomas
,
T. Giordano
,
K. McDonagh
,
L. Baker
Pediatric Blood & Cancer
2013
Corpus ID: 45274077
BACKGROUND The role of erbB tyrosine kinases, especially Her-2, in osteosarcoma has engendered intense debate. Some investigators…
Expand
2013
2013
Expressions and clinical significance of HER-3 and HER-4 in gastric carcinoma
X. Lei
2013
Corpus ID: 75720863
Objective To investigate the expressions and clinical significance of human epidermal growth factor receptors of 3 and 4(HER-3…
Expand
2011
2011
PD05-03: Impact of Quantitative Measurement of HER2, HER3, HER4, EGFR, ER and PTEN Protein Expression on Benefit to Adjuvant Trastuzumab in Early-Stage HER2+ Breast Cancer Patients in NCCTG N9831.
E. Perez
,
K. Ballman
,
+16 authors
D. Rimm
2011
Corpus ID: 71830824
Background: Prediction of benefit from trastuzumab in patients (pts) with HER2+ breast cancer remains an important goal. We…
Expand
2011
2011
Nuclear HER-4 (4ICD) and Estrogen Receptor α in non-small-cell lung carcinoma
Christina Karlsson
,
G. Helenius
,
M. Karlsson
2011
Corpus ID: 68331476
Non-small cell lung carcinoma is a leading cause of cancer mortality worldwide. There are gender and smoking associated…
Expand
2010
2010
[Model in vivo to study the transdifferentiation of the somatic cell into urothelium].
B. Popov
,
A. Zaichik
,
+6 authors
B. K. Komiakov
Tsitologiya
2010
Corpus ID: 45301195
Development of reconstructive therapy of the urinary tract using pluripotent and somatic stem cells, for example mesenchymal stem…
Expand
2007
2007
Association of Wwox with ErbB 4 in Breast Cancer
R. Aqeilan
,
V. Donati
,
+9 authors
K. Elenius
2007
Corpus ID: 26364007
WWOX , WW domain-containing oxidoreductase, is a tumor suppressor that is altered in many human cancers, including breast cancer…
Expand
2005
2005
Συσχέτιση ευρημάτων μαστογραφίας και προγνωστικών δεικτών σε μη - ψηλαφητές βλάβες μαστού
Φιλίτσα-Λεμονιά Μπάδρα
2005
Corpus ID: 74968448
Screening mammography has greatly increased the number of non-palpable breast carcinomas diagnosed in asymptomatic women…
Expand
2001
2001
Endocrine-Related Cancer ( 2001 ) 8 83 – 96 EGF mutant receptor vIII as a molecular target in cancer therapy
C. Kuan
,
C. Wikstrand
,
D. D. Bigner
2001
Corpus ID: 64737906
In the year 2000, an estimated 1220 100 new cases of invasive cancer will be diagnosed in the United States, and about 552 200…
Expand